ENTRY       D01896                      Drug
NAME        Cilostazol (JP18/USP/INN);
            Pletal (TN)
PRODUCT
  GENERIC   CILOSTAZOL (A-S Medication Solutions)
            CILOSTAZOL (A-S Medication Solutions)
            CILOSTAZOL (Aphena Pharma Solutions - Tennessee)
            CILOSTAZOL (Apotex Corp.)
            CILOSTAZOL (AvKARE)
            CILOSTAZOL (AvPAK)
            CILOSTAZOL (Bryant Ranch Prepack)
            CILOSTAZOL (Bryant Ranch Prepack)
            CILOSTAZOL (REMEDYREPACK)
            CILOSTAZOL (REMEDYREPACK)
            CILOSTAZOL (Slate Run Pharmaceuticals)
            CILOSTAZOL (Teva Pharmaceuticals USA)
            CILOSTAZOL (West-Ward Pharmaceuticals Corp.)
            CILOSTAZOL (direct rx)
FORMULA     C20H27N5O2
EXACT_MASS  369.2165
MOL_WEIGHT  369.4607
CLASS       Cardiovascular agent
             DG01507  Phosphodiesterase III inhibitor
            Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
            Metabolizing enzyme substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 3399
            ATC code: B01AC23
            Product: D01896<JP/US>
EFFICACY    Vasodilator, Platelet aggregation inhibitor, Phosphodiesterase inhibitor
TARGET      PDE3 [HSA:5139 5140] [KO:K19021 K13296]
            TBXA2R [HSA:6915] [KO:K04264]
  PATHWAY   hsa00230(5139+5140)  Purine metabolism
            hsa04022(5139+5140)  cGMP-PKG signaling pathway
            hsa04024(5139+5140)  cAMP signaling pathway
            hsa04611(6915)  Platelet activation
            hsa04910(5140)  Insulin signaling pathway
            hsa04922(5140)  Glucagon signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]; CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]
INTERACTION  
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC23 Cilostazol
                  D01896  Cilostazol (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Platelet Modifying Agents
               Platelet Modifying Agents, Other
                Cilostazol
                 D01896  Cilostazol (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D01896  Cilostazol (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01507  Phosphodiesterase III inhibitor
               D01896  Cilostazol
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                D01896  Cilostazol
             Metabolizing enzyme substrate
              DG01639  CYP2C19 substrate
               D01896  Cilostazol
              DG01644  CYP2D6 substrate
               D01896  Cilostazol
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D01896  Cilostazol
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Thromboxane
                TBXA2R
                 D01896  Cilostazol (JP18/USP/INN) &lt;JP/US&gt;
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE3
                 D01896  Cilostazol (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01896  Cilostazol
              D01896  Cilostazol tablets
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01896
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01896
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01896
DBLINKS     CAS: 73963-72-1
            PubChem: 7848958
            ChEBI: 31401
            LigandBox: D01896
            NIKKAJI: J23.223H
ATOM        27
            1   C1y C    21.6291  -13.6161
            2   C1x C    21.6291  -15.0158
            3   C1x C    20.4140  -15.7157
            4   C1x C    19.2060  -15.0158
            5   C1x C    19.2060  -13.6161
            6   C1x C    20.4140  -12.9162
            7   N4y N    22.8410  -12.9155
            8   C8y C    22.8310  -11.5237
            9   N5x N    24.1537  -11.0795
            10  N5x N    24.9846  -12.2002
            11  N5x N    24.1756  -13.3370
            12  C8y C    13.1531  -11.4954
            13  C8y C    13.1600  -12.9021
            14  N1x N    11.9445  -13.6081
            15  C5x C    10.7217  -12.9144
            16  C1x C    10.7146  -11.5078
            17  C1x C    11.9303  -10.7947
            18  C8y C    15.5755  -11.5086
            19  C8x C    15.5771  -12.9086
            20  C8x C    14.3572  -13.6076
            21  C8x C    14.3592  -10.7940
            22  O5x O     9.5059  -13.6203
            23  O2a O    16.7868  -10.8096
            24  C1b C    17.9956  -11.5095
            25  C1b C    19.2045  -10.8167
            26  C1b C    20.4133  -11.5166
            27  C1b C    21.6222  -10.8239
BOND        30
            1     1   7 1
            2     1   2 1
            3     2   3 1
            4     3   4 1
            5     4   5 1
            6     7   8 1
            7     8   9 2
            8     9  10 1
            9    13  14 1
            10   18  19 1
            11   19  20 2
            12   20  13 1
            13   12  21 1
            14   21  18 2
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  12 1
            19   12  13 2
            20   15  22 2
            21   10  11 2
            22   18  23 1
            23   11   7 1
            24   23  24 1
            25    5   6 1
            26   24  25 1
            27    6   1 1
            28   25  26 1
            29   26  27 1
            30   27   8 1
///
